WallStreetZenWallStreetZen

NASDAQ: RSLS
Reshape Lifesciences Inc Stock Ownership - Who owns Reshape Lifesciences?

Insider buying vs selling

Have Reshape Lifesciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Thomas StankovichChief Financial Officer2023-10-25131$0.27
$35.37Sell
Thomas StankovichChief Financial Officer2023-10-1139$0.93
$36.27Sell
Thomas StankovichChief Financial Officer2023-09-01118$0.89
$105.02Sell
Thomas StankovichChief Financial Officer2023-08-2439$1.42
$55.38Sell
Thomas StankovichChief Financial Officer2023-08-04108$1.43
$154.44Sell
Thomas StankovichChief Financial Officer2023-07-06106$1.47
$155.82Sell
Thomas StankovichChief Financial Officer2023-06-3017,702$1.52
$26.91kBuy
Thomas StankovichChief Financial Officer2023-05-3198$2.41
$236.18Sell
Thomas StankovichChief Financial Officer2023-04-3096$2.36
$226.56Sell
Thomas StankovichChief Financial Officer2023-03-31109$2.60
$283.40Sell

1 of 1

RSLS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RSLS insiders and whales buy or sell their stock.

RSLS Shareholders

What type of owners hold Reshape Lifesciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC109.98%14,446,692$2.63MInsider
Yair Schneid18.74%2,461,000$447.90kInsider
Andrew P. Rasdal7.45%978,882$178.16kInsider
Domain Parters Vii L P6.19%813,433$148.04kInsider
Barton P. Bandy5.89%773,098$140.70kInsider
Interwest Partners X LP2.89%380,224$69.20kInsider
Dan W. Gladney2.16%283,922$51.67kInsider
Lori Courtney McDougal1.93%253,429$46.12kInsider
Gary Blackford1.93%253,429$46.12kInsider
Arda Phd Minocherhomjee1.93%253,429$46.12kInsider

1 of 3

RSLS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RSLS1.95%98.05%Net Buying
TNON15.35%84.65%Net Buying
THMO0.26%99.74%Net BuyingNet Buying
DYNT3.10%96.90%Net Buying
MOTS0.73%99.27%

Reshape Lifesciences Stock Ownership FAQ

Who owns Reshape Lifesciences?

Reshape Lifesciences (NASDAQ: RSLS) is owned by 3.31% institutional shareholders, 166.19% Reshape Lifesciences insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Reshape Lifesciences shareholder, owning 14.45M shares representing 109.98% of the company. Armistice Capital LLC's Reshape Lifesciences shares are currently valued at $2.61M.

If you're new to stock investing, here's how to buy Reshape Lifesciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.